Thierry André
机构: Hôpital Saint Antoine
每年引用次数
引用次数
引用: 59,871
H-指数: 100
I10-指数 : 390
出版物: 1,131
Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group.
Amandine Crombé , Michèle Kind , Isabelle Ray-Coquard , Nicolas Isambert
American Journal of Roentgenology 215 ( 6) 1539 -1548
3
2020
Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma.
Jean-Baptiste Bachet , Fabien Gay , Raphaël Maréchal , Marie-Pierre Galais
Pancreas 44 ( 7) 1141 -1147
36
2015
Simplified Prognostic Model in Patients with Oxaliplatin-Based or Irinotecan-Based First-Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR Study
Benoist Chibaudel , Franck Bonnetain , Christophe Tournigand , Leila Bengrine‐Lefevre
Oncologist 16 ( 9) 1228 -1238
57
2011
Folliculitis Induced by EGFR Inhibitors, Preventive and Curative Efficacy of Tetracyclines in the Management and Incidence Rates According to the Type of EGFR Inhibitor Administered: A Systematic Literature Review
Jean‐Baptiste Bachet , Lucie Peuvrel , Claude Bachmeyer , Ziad Reguiai
Oncologist 17 ( 4) 555 -568
44
2012
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study
Eric Van Cutsem , Erika Martinelli , Stefano Cascinu , Alberto Sobrero
Oncologist 24 ( 2) 185 -192
36
2019
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael J Overman , Ray McDermott , Joseph L Leach , Sara Lonardi
Lancet Oncology 18 ( 9) 1182 -1191
2,048
2017
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study
Stefano Kim , Eric François , Thierry André , Emmanuelle Samalin
Lancet Oncology 19 ( 8) 1094 -1106
40
2018
Prognostic score and nomogram to predict overall survival in locally advanced pancreatic cancer
Dewi Vernerey , David Goldstein , Florence Huguet , Sophie Paget-Bailly
Pancreatology 15 ( 3)
2015
Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: Study design and preliminary safety results
Thierry André , Philippe Colin , Christophe Louvet , Erick Gamelin
Seminars in Oncology 28 ( 1) 35 -40
19
2001
Levels of Gemcitabine Transport and Metabolism Proteins Predict Survival Times of Patients Treated With Gemcitabine for Pancreatic Adenocarcinoma
Raphaël Maréchal , Jean–Baptiste Bachet , John R Mackey , Cécile Dalban
Gastroenterology 143 ( 3) 664 -674.e6
178
2012
Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer
Mairéad Geraldine McNamara , Andre Lopes , Harpreet Wasan , David Malka
Journal of Hepatology 73 ( 5) 1109 -1117
3
2020
Cetuximab-induced acne.
Emmanuel Molinari , Julie De Quatrebarbes , Thierry André , Sélim Aractingi
Dermatology 211 ( 4) 330 -333
58
2005
Differential expression of the CCK‐A and CCK‐B/gastrin receptor genes in human cancers of the esophagus, stomach and colon
Pascal Clerc , Marlène Dufresne , Corinne Saillan , Eric Chastre
International Journal of Cancer 72 ( 6) 931 -936
58
1997
Immune checkpoint inhibitors for patients with colorectal cancer: mismatch repair deficiency and perspectives
Romain Cohen , Magali Svrcek , Alex Duval , Yann Parc
Colorectal cancer 6 ( 1) 23 -31
1
2017
Adjuvant therapy in patients with stage II and III colon cancer under 70 years of age
Sarah N Dumont , Benoist Chibaudel , Leïla Bengrine-Lefèvre , Thierry André
Colorectal cancer 2 ( 3) 205 -217
2013
Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial
Zeinab Hamidou , Benoist Chibaudel , Mohamed Hebbar , Marine Hug de Larauze
PLOS ONE 11 ( 6) e0157067
9
2016
Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study.
Emily Nash Smyth , Bela Bapat , Daniel E. Ball , Thierry André
Clinical Therapeutics 37 ( 6) 1301 -1316
19
2015
Patient-reported outcomes in DNA mismatch repair deficient/microsatellite instability high metastatic colorectal cancer treated with nivolumab: CheckMate 142
Michael Overman , Shital Kamble , Rebecca Moss , Fiona Taylor
Annals of Oncology 28
4
2017
Randomized trial of simplified LV5FU2 versus FOLFOX7 followed by FOLFIRI (MIROX) in patients with initially resectable metastatic colorectal cancer: a GERCOR study
Mohamed Hebbar , Benoist Chibaudel , Thierry André , Christophe Louvet
Journal of Chemotherapy 25 ( 2) 104 -111
8
2013
Identification of Positively and Negatively Selected Driver Gene Mutations Associated With Colorectal Cancer With Microsatellite Instability.
Vincent Jonchere , Laetitia Marisa , Malorie Greene , Alain Virouleau
Cellular and molecular gastroenterology and hepatology 6 ( 3) 277 -300
9
2018